Bluejay Diagnostics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BJDX Nasdaq 3840 bluejaydx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bluejay Diagnostics, Inc.

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - Jan 27th, 2026 6:00 am
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production - Dec 29th, 2025 5:00 am
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships - Nov 10th, 2025 5:30 am
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Oct 10th, 2025 3:16 pm
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Oct 9th, 2025 1:15 pm
Traders Digest Earnings, Powell Speech, Driving Muted Premarket Action for US Equity Futures - Oct 9th, 2025 7:07 am
Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform - Oct 9th, 2025 4:30 am
BC-Most Active Stocks - Aug 11th, 2025 8:30 am
Bluejay Diagnostics Provides Second Quarter Business and Corporate Update - Aug 7th, 2025 4:30 pm
Bluejay Diagnostics Provides Mid-Year Business and Corporate Update - Jun 3rd, 2025 2:05 pm
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - Apr 15th, 2025 5:00 am
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - Apr 7th, 2025 3:21 pm